Do analysts think you should hold?


Investors Observer gives Applied DNA Sciences Inc (APDN) an analyst rating of 74, meaning APDN is ranked higher by analysts than 74% of stocks. The average price target for APDN is $16.666 and analysts rate the stock as a strong buy.

Wall Street analysts today rate APDN as a strong buy. Find out what this means for you and get the rest of the rankings on APDN!

Why are analyst ratings important?

Analysts know better than anyone the inner workings of the companies they follow, except for the management of the companies. You can tell a lot about a company by studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in any part of the world can disrupt supply chains or disrupt shopping habits. This allows traders to make decisions **ahead** of a quarterly report that could be worse than expected.

Investors Observer aggregates the ratings of all analysts covering a given stock, takes the average of those ratings, and then ranks the averages into percentiles. This provides a much better level of granularity than the three levels provided by traditional buy/hold/sell notations.

What’s going on with Applied DNA Sciences Inc stock today?

Applied DNA Sciences Inc (APDN) stock is trading at $4.30 at 3:00 p.m. Wednesday, January 12, a gain of $0.03, or 0.7% from the previous closing price of 4, $27. The stock has traded between $4.18 and $4.30 so far today. The volume today is light. So far, 22,424 shares have been traded against an average volume of 379,583 shares. Click here for the full Applied DNA Sciences Inc stock report.


Comments are closed.